Hart RG, Diener H-C, Coutts SB, Easton JD, Granger CB, O’Donnell MJ, et al (2014) Embolic strokes of undetermined source: the case for a new clinical construct. The Lancet Neurology 13:429–38

Kent DM, Dahabreh IJ, Ruthazer R, Furlan AJ, Reisman M, Carroll JD et al (2016) Device closure of patent foramen ovale after stroke: pooled analysis of completed randomized trials. J Am Coll Cardiol 67:907–17

Article  PubMed  PubMed Central  Google Scholar 

Homma S, Messé SR, Rundek T, Sun Y-P, Franke J, Davidson K et al (2016) Patent foramen ovale. Nat Rev Dis Primers 2:15086

Article  PubMed  Google Scholar 

Overell JR, Bone I, Lees KR (2000) Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55:1172–9

Article  CAS  PubMed  Google Scholar 

Alsheikh-Ali AA, Thaler DE, Kent DM (2009) Patent foramen ovale in cryptogenic stroke: incidental or pathogenic? Stroke 40:2349–55

Article  PubMed  PubMed Central  Google Scholar 

Caso V, Turc G, Abdul-Rahim AH, Castro P, Hussain S, Lal A, et al (2024) European Stroke Organisation (ESO) Guidelines on the diagnosis and management of patent foramen ovale (PFO) after stroke. Eur Stroke J 9:800–34.

Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D et al (2021) 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke 52:e364–467

Article  PubMed  Google Scholar 

Kavinsky CJ, Szerlip M, Goldsweig AM, Amin Z, Boudoulas KD, Carroll JD et al (2022) SCAI guidelines for the management of patent foramen ovale. Journal of the Society for Cardiovascular Angiography & Interventions. https://doi.org/10.1016/j.jscai.2022.100039

Article  Google Scholar 

Mazzucco S, Li L, Rothwell PM (2020) Prognosis of cryptogenic stroke with patent foramen ovale at older ages and implications for trials: a population-based study and systematic review. JAMA Neurol 77:1279–87

Article  PubMed  PubMed Central  Google Scholar 

Lee PH, Kim J-S, Song J-K, Kwon SU, Kim BJ, Lee JS, et al (2024) Device Closure or Antithrombotic Therapy After Cryptogenic Stroke in Elderly Patients With a High-Risk Patent Foramen Ovale. J Stroke 26:242–51

Chen P-L, Wang C-S, Huang J-A, Fu Y-C, Liao N-C, Hsu C-Y, et al (2023) Patent foramen ovale closure in non-elderly and elderly patients with cryptogenic stroke: a hospital-based cohort study. Front Neurol 14:1190011

Windecker S, Wahl A, Nedeltchev K, Arnold M, Schwerzmann M, Seiler C, et al (2004) Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 44:750–8

Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (2019) Cochrane Handbook for Systematic Reviews of Interventions. 2nd Edition. Chichester (UK): John Wiley & Sons (eds)

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71.

Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919

Higgins JPT, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–58

Article  PubMed  Google Scholar 

Smer A, Salih M, Mahfood Haddad T, Guddeti R, Saadi A, Saurav A et al (2018) Meta-analysis of randomized controlled trials on patent foramen ovale closure versus medical therapy for secondary prevention of cryptogenic stroke. Am J Cardiol 121:1393–9

Article  PubMed  Google Scholar 

Ahmad Y, Howard JP, Arnold A, Shin MS, Cook C, Petraco R, et al (2018) Patent foramen ovale closure vs. medical therapy for cryptogenic stroke: a meta-analysis of randomized controlled trials. Eur Heart J 39:1638–49

Vazquez-Sosa C, Clegg SD, Blankenship JC (2021) How old is too old? Closure of patent foramen ovale in older patients. US Cardiol 15:e20

Article  PubMed  PubMed Central  Google Scholar 

Satpathy R, Rodés-Cabau J, Thaler DE, Kent DM, Turner S, Potluri S, et al (2025) PFO Device Closure in Patients > 60 Years of Age With Ischemic Stroke: Results From U.S. Medicare Beneficiaries. JACC Cardiovasc Interv 18:1303–14

Alperi A, Guedeney P, Horlick E, Nombela-Franco L, Freixa X, Pascual I et al (2022) Transcatheter closure of patent foramen ovale in older patients with cryptogenic thromboembolic events. Circ Cardiovasc Interv 15:e011652

Article  CAS  PubMed  Google Scholar 

Wang AY, Rothwell PM, Nelson J, Saver JL, Kasner SE, Carroll J, et al (2024) Patent Foramen Ovale Closure in Older Patients With Stroke: Patient Selection for Trial Feasibility. Neurology 102:e209388

Wang C-S, Wu Y-H, Fu Y-C, Jan S-L, Lin M-C, Hsu C-Y et al (2025) Assessment of patent foramen ovale closure in elderly patients with cryptogenic transient ischemic attack or stroke: efficacy, safety, and potential age-related benefit. Eur Stroke J. https://doi.org/10.1177/23969873251341764

Article  PubMed  PubMed Central  Google Scholar 

Chen J-J, Thijs VN (2021) Atrial fibrillation following patent foramen ovale closure: systematic review and meta-analysis of observational studies and clinical trials. Stroke 52:1653–61

Article  PubMed  Google Scholar 

Eichelmann A, Kubini R, Nachoski D, Kosinski C, Becker M, Aljalloud A. Patent foramen ovale closure versus drug therapy in patients over 60 years and a follow-up of 5 years. Clin Cardiol. 2024;47(3):e24251.

Kwon H, Lee PH, Song JK, Kwon SU, Kang DW, Kim JS. Patent Foramen Ovale Closure in Old Stroke Patients: A Subgroup Analysis of the DEFENSE-PFO Trial. J Stroke.

Wahl A, Jüni P, Mono ML, et al. Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism. Circulation. 2012;125(6):803-812.